Basilea Pharmaceutica Ltd.. (3/1/18). "Press Release: Basilea Names Adesh Kaul as New Member of its Management Committee". Basel. |
2018-03-01 |
Enzymicals AG. (3/1/18). "Press Release: Signed Cooperation Agreement. Special Chemical Manufacturers abcr GmbH and Enzymicals AG Want to Make Use of Synergies". Greifswald & Karlsruhe. |
2018-03-01 |
R-Biopharm AG. (3/1/18). "Press Release: R-Biopharm AG & Bosch Healthcare Solutions Partner to Develop Molecular Diagnostics for Automated All-in-One Platform". Darmstadt & Waiblingen. |
2018-03-01 |
BioMedPartners AG. (3/1/18). "Press Release: BioMedPartners Close Their New Healthcare Venture Fund BioMedInvest III at CHF 100 Million". Basel. |
2018-03-01 |
Rentschler Biopharma SE. (2/28/18). "Press Release: Rentschler Biopharma SE Appoints Federico Pollano as Senior Vice President, Business Development". Laupheim. |
2018-02-28 |
BRAIN AG. (2/28/18). "Press Release: BRAIN AG Starts the Financial Year 2017/18 with a Weak First Quarter". Zwingenberg. |
2018-02-28 |
ERS Genomics Ltd.. (2/28/18). "Press Release: European Patent Office Grants Second Charpentier/Doudna Patent Covering CRISPR-Cas9 Gene Regulation Applications". Dublin. |
2018-02-28 |
German Accelerator Life Sciences. (2/28/18). "Press Release: German Accelerator Life Sciences Appoints Vice President Germany". Berlin & Cambridge, MA. |
2018-02-28 |
Thermo Fisher Scientific Inc.. (2/28/18). "Press Release: Thermo Fisher Supplies Analytical Instruments to World Anti-Doping Agency Laboratory in South Korea". Waltham, MA. |
2018-02-28 |
Novo Holdings A/S. (2/27/18). "Press Release: Novo Holdings Launches USD 165m Impact Fund to Combat Antimicrobial Resistance". Copenhagen. |
2018-02-27 |
Basilea Pharmaceutica Ltd.. (2/27/18). "Press Release: Basilea Reports Significantly Improved Financial Results in 2017". Basel. |
2018-02-27 |
Hume Brophy. (2/27/18). "Press Release: Hume Brophy International Healthcare Launches New Life Sciences Division". London. |
2018-02-27 |
Selexis S.A.. (2/26/18). "Press Release: Xencor Signs Four Commercial License Agreements with Selexis SA to Advance its Pipeline of XmAb Bispecific Antibody Drug Candidates". Geneva. |
2018-02-26 |
Valneva S.E.. (2/26/18). "Press Release: Emergent BioSolutions and Valneva Initiate Phase 1 Clinical Study to Evaluate Vaccine Candidate against Zika Virus". Gaithersburg, MD & Lyon. |
2018-02-26 |
Bruker Corporation. (2/26/18). "Press Release: Bruker Highlights Innovative Analytical Solutions and Systems at Pittcon". Orlando, FL. |
2018-02-26 |
Berlin Cures Holding AG. (2/26/18). "Press Release: Heart Failure Treatment from Berlin Cures Shows Promise in Phase 1 Study". Zug & Berlin. |
2018-02-26 |
Miltenyi Biotec GmbH. (2/26/18). "Press Release: MolMed and Miltenyi Biotec. EMA Approves the Utilization of the CliniMACS Prodigy Equipment". Milan & Bergisch Gladbach. |
2018-02-26 |
AiCuris Anti-infective Cures GmbH. (2/23/18). "Press Release: AiCuris’ Licensee MSD Launches Prevymis (letermovir) in Germany". Wuppertal. |
2018-02-23 |
Basilea Pharmaceutica Ltd.. (2/23/18). "Press Release: Basilea Reports Clinical Phase 3 Study Start with Antibiotic Ceftobiprole in Skin Infections under BARDA Contract". Basel. |
2018-02-23 |
BCNP Consultants GmbH. (2/23/18). "Press Release: More than 1,200 Meetings at the 2nd European Chemistry Partnering". Frankfurt a. M.. |
2018-02-23 |
Qiagen N.V.. (2/23/18). "Press Release: Qiagen Opens Shared Services Center in Taguig City, Manila". Manila. |
2018-02-23 |
Streck, Inc.. (2/23/18). "Press Release: Streck, Inc. Files Suit against Cenata GmbH for Infringement of Its European Patent". La Vista, NE. |
2018-02-23 |
BRAIN AG. (2/22/18). "Press Release: BRAIN AG Expands Patent Protection for Unique Taste Cell Technology to Europe". |
2018-02-22 |
Bruker Corporation. (2/22/18). "Press Release: Bruker Acquires High-Speed QCL Infrared Microscopy Company IRM²". Ettlingen. |
2018-02-22 |
Medigene AG. (2/21/18). "Press Release: Medigene Receives Approvals for Its First Clinical Trial with TCR Therapy MDG1011". Planegg. |
2018-02-21 |
Basilea Pharmaceutica Ltd.. (2/21/18). "Press Release: Basilea's CEO Ronald Scott Will Retire. Chief Commercial Officer David Veitch Named as Successor – Changes in the Board of Directors". Basel. |
2018-02-21 |
Bruker Corporation. (2/21/18). "Press Release: Bruker Announces Resignation of Chief Financial Officer and Appointment of Principal Accounting Officer". Billerica, MA. |
2018-02-21 |
G1 Therapeutics, Inc.. (2/21/18). "Press Release: G1 Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results and Recent Operational Highlights". Research Triangle Park, NC. |
2018-02-21 |
Merck KGaA. (2/21/18). "Press Release: Merck Invests Additional €40 Million to Enhance Manufacturing and Distribution in Asia". Darmstadt. |
2018-02-21 |
Cullinan Oncology, LLC. (2/20/18). "Press Release: Cullinan Oncology and MAB Discovery Announce Collaboration to Develop Novel Antibody-Based Therapeutics". Cambridge, MA & Neuried. |
2018-02-20 |
Bruker Corporation. (2/20/18). "Press Release: Bruker Announces Quarterly Dividend". Billerica, MA. |
2018-02-20 |
Minoryx Therapeutics S.L.. (2/20/18). "Press Release: Minoryx Therapeutics Spins Off SEE-Tx Platform into New Company, Gain Therapeutics". Mataró, Barcelona & Lugano. |
2018-02-20 |
Siemens AG. (2/19/18). "Press Release: Siemens Plans IPO of Siemens Healthineers AG in the First Half of Calendar Year 2018 [Not for United States, Australia, Canada or Japan]". Erlangen & Munich. |
2018-02-19 |
Avillion LLP. (2/16/18). "Press Release: Avillion Advances Co-development Programme with Merck. IND Now Open for Phase 2 Study of M1095, an anti-IL-17 A/F Nanobody in Psoriasis". London. |
2018-02-16 |
Pieris Pharmaceuticals, Inc.. (2/16/18). "Press Release: Pieris Pharmaceuticals Announces Closing of Public Offering and Exercise of Underwriters' Option to Purchase Additional Shares". Boston, MA. |
2018-02-16 |
Affimed N.V.. (2/15/18). "Press Release: Affimed Announces Closing of Public Offering of Common Stock and Exercise of Underwriters’ Option to Purchase Additional Shares". Heidelberg. |
2018-02-15 |
Addex Therapeutics S.A.. (2/15/18). "Press Release: Addex Launches CHF40 million Capital Increase with Commitments from Specialist US Healthcare Investors". Geneva. |
2018-02-15 |
Roche. (2/15/18). "Press Release: Roche to Acquire Flatiron Health to Accelerate Industry-wide Development and Delivery of Breakthrough Medicines for Patients with Cancer". Basel. |
2018-02-15 |
Merck KGaA. (2/15/18). "Press Release: Merck and Pfizer Provide Update on Phase III JAVELIN Lung 200 Trial of Avelumab Monotherapy in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer [Not intended for UK-based media]". Darmstadt. |
2018-02-15 |
ABAC Therapeutics. (2/15/18). "Press Release: ABAC Therapeutics Announces €16 Million Series A to Develop Therapeutic Solutions to Fight Antibiotic-resistant Bacteria". Barcelona. |
2018-02-15 |
Cell Medica Ltd.. (2/15/18). "Press Release: Cell Medica Announces the Appointment of Kevin Boyle as Chief Financial Officer". |
2018-02-15 |
Bruker Corporation. (2/14/18). "Press Release: The Bruker MALDI Biotyper Solution Receives AOAC International Approvals for Two Official Methods of Analysis (OMA) in Food Microbiology". Billerica, MA. |
2018-02-14 |
Recipharm AB. (2/14/18). "Press Release: Recipharm Appoints President Development Services to Drive End to End Offering". |
2018-02-14 |
Affimed N.V.. (2/13/18). "Press Release: Affimed Announces Pricing of Public Offering of Common Stock". Heidelberg. |
2018-02-13 |
Gilde Healthcare Partners. (2/13/18). "Press Release: Gilde Healthcare Company RAD-x Continues Buy & Build with Acquisition of Swiss Medical Imaging Centers". Utrecht. |
2018-02-13 |
Sciomics GmbH. (2/12/18). "Press Release: Sciomics Participates in Collaborative Clinical Trials for the Treatment of Metaphyseal Chondrodysplasia Type Schmid (MCDS)". Heidelberg. |
2018-02-12 |
Affimed N.V.. (2/12/18). "Press Release: Affimed Announces Proposed Public Offering of Common Stock". Heidelberg. |
2018-02-12 |
Lonza Group AG. (2/12/18). "Press Release: Lonza Expands Cell-Culture Portfolio with Quasi Vivo System". Basel. |
2018-02-12 |
Pieris Pharmaceuticals, Inc.. (2/9/18). "Press Release: Pieris Pharmaceuticals and Seattle Genetics Announce Multi-Program Immuno-Oncology Collaboration". Boston, MA & Bothell, WA. |
2018-02-09 |
Boehringer Ingelheim. (2/9/18). "Press Release: Boehringer Ingelheim Refocuses PDE9 Inhibition Brain Research on Schizophrenia Following Results from Phase II Alzheimer’s Trials". Ingelheim. |
2018-02-09 |
Bruker Corporation. (2/8/18). "Press Release: Bruker Reports Fourth Quarter and Fiscal Year 2017 Financial Results". Billerica, MA. |
2018-02-08 |
Fluidigm Corporation. (2/8/18). "Press Release: Fluidigm Announces Fourth Quarter and Full Year 2017 Financial Results and Operational Progress". South San Francisco, CA. |
2018-02-08 |
Genedata AG. (2/8/18). "Press Release: Genedata Bioprocess Licensed to Pfizer Inc.". Basel. |
2018-02-08 |
Lonza Group Ltd.. (2/8/18). "Press Release: Denali Therapeutics and Lonza Pharma & Biotech Announce Exclusive Partnership to Develop and Produce Biologic Medicines". Basel & South San Francisco, CA. |
2018-02-08 |
University of Bayreuth. (2/8/18). "Press Release: Innovative Research Infrastructure with a Global Reputation. The Northern Bavarian NRM Centre Repositions Itself". |
2018-02-08 |
c-LEcta GmbH. (2/8/18). "Press Release: c-LEcta Closes Exclusive Supply Agreement with Global Pharma Company". |
2018-02-08 |
Ablynx N.V.. (2/7/18). "Press Release: Ablynx Announces Board Changes". Ghent. |
2018-02-07 |
Addex Therapeutics S.A.. (2/7/18). "Press Release: Addex Appoints Jean-Philippe Rocher as Co-Head of Discovery and Member of the Executive Management". Geneva. |
2018-02-07 |
Analytik Jena AG. (2/7/18). "Press Release: Laboratory Automation Solution Designed to Boost Productivity Showcased at SLAS 2018". San Diego, CA & Jena. |
2018-02-07 |
Lonza Group Ltd.. (2/7/18). "Press Release: Lonza Partners with Prolog Ventures to Establish VC Fund to Invest in Consumer Health and Wellness Startups". Basel. |
2018-02-07 |
Sanofi S.A.. (2/7/18). "Press Release: Sanofi Delivers 2017 Business EPS(1) in Line with Guidance". Paris. |
2018-02-07 |
ProBioGen AG. (2/7/18). "Press Release: ProBioGen and Teva Sign License Agreement on Human Artificial Lymph Node Technology". Berlin. |
2018-02-07 |
ImmunoQure AG. (2/6/18). "Press Release: Servier and ImmunoQure AG Enter into Strategic Partnership for the Development of an Interferon-alpha Human Autoantibody". Paris & Düsseldorf. |
2018-02-06 |
Genedata AG. (2/6/18). "Press Release: Genedata Announces New Solution for NGS-Based Biosafety Assessment". Basel. |
2018-02-06 |
Idorsia Ltd.. (2/6/18). "Press Release: Idorsia Announces Financial Results for 2017 – Company Off to a Great Start – 4 Compounds to Enter Phase 3 Development". Allschwil. |
2018-02-06 |
InflaRx N.V.. (2/6/18). "Press Release: InflaRx Announces Appointment of Tony Gibney to Its Board of Directors". Jena. |
2018-02-06 |
Selvita S.A.. (2/6/18). "Press Release: Selvita Appoints Steffen Heeger, M.D., PhD as Chief Medical Officer". Kraków. |
2018-02-06 |
Sophia Genetics S.A.. (2/6/18). "Press Release: Sophia Genetics Announces CE-IVD Marking of Its Genomic Test for Leukemia Detection". Lausanne. |
2018-02-06 |
Faron Pharmaceuticals Oy. (2/5/18). "Press Release: Faron Establishes Second Traumakine Manufacturing Site". Turku. |
2018-02-05 |
Addex Therapeutics S.A.. (2/5/18). "Press Release: Addex Provides Key Financial Indicators and Trading Update. Cash Position of CHF6.5 million as of 31 January 2018". Geneva. |
2018-02-05 |
SGS S.A.. (2/2/18). "Press Release: SGS Acquires TraitGenetics GmbH, Germany". |
2018-02-02 |
Genedata AG. (2/2/18). "Press Release: Genedata Profiler Powers Major Breakthroughs in Early Prediction of Breast and Ovarian Cancer". Basel. |
2018-02-02 |
4SC AG. (2/1/18). "Press Release: Positive DSMB Safety Review of 4SC’s Pivotal RESMAIN Study of Resminostat in CTCL". Planegg-Martinsried. |
2018-02-01 |
Medigene AG. (2/1/18). "Press Release: Medigene Strengthens Its Patent Portfolio with a US Patent on a Tagged TCR". Planegg. |
2018-02-01 |
Lab Automation Network (LAN). (2/1/18). "Press Release: Cytosurge AG and Lab Automation Network Announce Partnership for Automated Single-cell Biology Applications". |
2018-02-01 |
Life Science Inkubator GmbH. (2/1/18). "Press Release: Life Science Inkubator (LSI) Bonn for the First Time Supports Pharma Industry Spin-out". |
2018-02-01 |
Miltenyi Biotec GmbH. (2/1/18). "Press Release: Cancer Coaching for the Immune System. Novel Cell Therapy Will Teach Immune Cells How to Fight Cancer". Teterow. |
2018-02-01 |
Arnold & Porter LLP. (2/1/18). "Press Release: Announcing Arnold & Porter". |
2018-02-01 |
Affimed N.V.. (2/1/18). "Press Release: Affimed Reports New Data for AFM13 from Two Separate Clinical Trials in Hodgkin and CD30-Positive Lymphomas". Heidelberg. |
2018-02-01 |
Qiagen N.V.. (1/31/18). "Press Release: Qiagen Enters into Agreement to Acquire STAT-Dx, Plans to Launch a Next-generation, Fully Integrated Multiplex Platform for Syndromic Disease Testing". Germantown, MD & Hilden. |
2018-01-31 |
Genedata AG. (1/31/18). "Press Release: Genedata Announces Genedata Screener for Massive Mechanistic Analysis". Basel. |
2018-01-31 |
Analytik Jena AG. (1/31/18). "Press Release: SLAS 2018 — Modular Liquid Handling System CyBio FeliX Automates New Process for Nucleic Acid Extraction". Jena. |
2018-01-31 |
Lonza Group AG. (1/31/18). "Press Release: Lonza Reports Record-breaking Full-year Results with Double-digit Lonza Standalone Sales Growth and More than 26% CORE EBIT Growth in a Major Transformational Year". Basel. |
2018-01-31 |
Sanofi S.A.. (1/31/18). "Press Release: Sanofi, DNDi Seek European Medicines Agency Review for Sleeping Sickness Treatment". Paris & Geneva. |
2018-01-31 |
AiCuris Anti-infective Cures GmbH. (1/31/18). "Press Release: Approval of MSD’s Prevymis (letermovir) by the European Commission Triggers the Next EUR 30 Million Milestone Payment for AiCuris". Wuppertal. |
2018-01-31 |
Oncgnostics GmbH. (1/31/18). "Press Release: Reliable Test for Cervical Cancer Triage Now Available in Slovakia and the Czech Republic". Jena. |
2018-01-31 |
Rentschler Biopharma SE. (1/31/18). "Press Release: Rentschler Biopharma SE Appoints International Biopharma Expert Dr. Ralf Otto as Chief Operating Officer". Laupheim. |
2018-01-31 |
Helsinn Healthcare S.A.. (1/30/18). "Press Release: Helsinn and the Scientific Centre of Monaco Sign Collaboration Agreement". Lugano. |
2018-01-30 |
Creathor Venture Management GmbH. (1/30/18). "Press Release: Creathor Invests in E-Health Platform »Humanoo«". Berlin & Bad Homburg v.d.H.. |
2018-01-30 |
BaseLaunch (BaselArea.swiss). (1/30/18). "Press Release: BaseLaunch up to a Solid Phase II Start". Basel. |
2018-01-30 |
Sanofi S.A.. (1/29/18). "Press Release: Sanofi to Acquire Ablynx for €3.9 Billion". Paris & Ghent. |
2018-01-29 |
Merck KGaA. (1/26/18). "Press Release: Dirk Toepfer Joins Merck as Chief Information Officer". Darmstadt. |
2018-01-26 |
Endress+Hauser AG. (1/26/18). "Press Release: Further Growth for Endress+Hauser in China. Third Plant Inaugurated in Suzhou". |
2018-01-26 |
Novartis AG. (1/26/18). "Press Release: Advanced Accelerator Applications Receives FDA Approval for Lutathera for Treatment of Gastroenteropancreatic Neuroendocrine Tumors". Basel. |
2018-01-26 |
Santhera Pharmaceuticals Holding AG. (1/26/18). "Press Release: Santhera Receives Negative CHMP Opinion on Appeal for Authorization of Raxone in Duchenne Muscular Dystrophy". Liestal. |
2018-01-26 |
Roche. (1/26/18). "Press Release: CHMP Recommends EU Approval of Roche’s Hemlibra for People with Haemophilia A with Inhibitors". Basel. |
2018-01-26 |
Illumina, Inc.. (1/26/18). "Press Release: Illumina Awarded $26.7M in Patent Suit Against Ariosa Diagnostics, Inc.". San Diego, CA. |
2018-01-26 |
ThromboGenics N.V.. (1/26/18). "Press Release: Novartis Pharma AG Holding 5.69% of ThromboGenics Equity Capital". Leuven. |
2018-01-26 |
Clariant. (1/25/18). "Press Release: SABIC Acquires 24.99% Stake in Clariant. SABIC Acquires Stakes Previously Held by 40 North and Corvex Management". Muttenz. |
2018-01-25 |
PerkinElmer, Inc.. (1/25/18). "Press Release: PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year 2017". Waltham, MA. |
2018-01-25 |